Literature DB >> 23395970

Adsorption of plasma proteins on uncoated PLGA nanoparticles.

Karim Sempf1, Tabiwang Arrey, Svetlana Gelperina, Tobias Schorge, Björn Meyer, Michael Karas, Jörg Kreuter.   

Abstract

The biodistribution of nanoparticles is significantly influenced by their interaction with plasma proteins. In order to optimize and possibly monitor the delivery of drugs bound to nanoparticles across the blood-brain barrier (BBB), the protein adsorption pattern of uncoated poly(lactic-co-glycolic acid) (PLGA) nanoparticles after their incubation in human plasma was studied by mass spectrometry. After washing of the particles with water, the proteins were directly digested on the nanoparticle surface using trypsin and then analyzed by nLC MALDI-TOF/TOF. Up to now, the standard method for investigation into the plasma protein adsorption to the particles was 2D gel electrophoresis (2D-PAGE), in certain cases followed by mass spectrometry. The non-gel-based method proposed in the present study provides novel insights into the protein corona surrounding the nanoparticles. The proteins adsorbed on the PLGA nanoparticles after incubation that gave the best signal in terms of quality (high MASCOT score) in human plasma were apolipoprotein E, vitronectin, histidine-rich glycoprotein and kininogen-1. These proteins also are constituents of HDL.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  2D-PAGE; HDL; MALDI-TOF/TOF; Mass spectrometry; Plasma proteins; Poly(lactide-co-glycolide) (PLGA) nanoparticles; Trypsin

Mesh:

Substances:

Year:  2013        PMID: 23395970     DOI: 10.1016/j.ejpb.2012.11.030

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  12 in total

1.  A critical evaluation of drug delivery from ligand modified nanoparticles: Confounding small molecule distribution and efficacy in the central nervous system.

Authors:  Rebecca L Cook; Kyle T Householder; Eugene P Chung; Alesia V Prakapenka; Danielle M DiPerna; Rachael W Sirianni
Journal:  J Control Release       Date:  2015-10-22       Impact factor: 9.776

Review 2.  Delivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities.

Authors:  Jessie L-S Au; Bertrand Z Yeung; Michael G Wientjes; Ze Lu; M Guillaume Wientjes
Journal:  Adv Drug Deliv Rev       Date:  2015-12-11       Impact factor: 15.470

3.  Comparative whole corona fingerprinting and protein adsorption thermodynamics of PLGA and PCL nanoparticles in human serum.

Authors:  Myolisi Ndumiso; Nela Buchtová; Lizex Husselmann; Gadija Mohamed; Ashwil Klein; Marique Aucamp; David Canevet; Sarah D'Souza; Retsepile E Maphasa; Frank Boury; Admire Dube
Journal:  Colloids Surf B Biointerfaces       Date:  2020-01-22       Impact factor: 5.268

Review 4.  PLGA's Plight and the Role of Stealth Surface Modification Strategies in Its Use for Intravenous Particulate Drug Delivery.

Authors:  Violet V Sheffey; Emily B Siew; Eden E L Tanner; Omolola Eniola-Adefeso
Journal:  Adv Healthc Mater       Date:  2022-01-27       Impact factor: 11.092

Review 5.  A Critical Review of the Use of Surfactant-Coated Nanoparticles in Nanomedicine and Food Nanotechnology.

Authors:  Taiki Miyazawa; Mayuko Itaya; Gregor C Burdeos; Kiyotaka Nakagawa; Teruo Miyazawa
Journal:  Int J Nanomedicine       Date:  2021-06-09

6.  Nanoencapsulation of ABT-737 and camptothecin enhances their clinical potential through synergistic antitumor effects and reduction of systemic toxicity.

Authors:  D Schmid; G E Jarvis; F Fay; D M Small; M K Greene; J Majkut; S Spence; K M McLaughlin; K D McCloskey; P G Johnston; A Kissenpfennig; D B Longley; C J Scott
Journal:  Cell Death Dis       Date:  2014-10-09       Impact factor: 9.685

7.  Comparison of cellular effects of starch-coated SPIONs and poly(lactic-co-glycolic acid) matrix nanoparticles on human monocytes.

Authors:  Dominik Gonnissen; Ying Qu; Klaus Langer; Cengiz Öztürk; Yuliang Zhao; Chunying Chen; Guiscard Seebohm; Martina Düfer; Harald Fuchs; Hans-Joachim Galla; Kristina Riehemann
Journal:  Int J Nanomedicine       Date:  2016-10-14

8.  Surface-modified gatifloxacin nanoparticles with potential for treating central nervous system tuberculosis.

Authors:  Patricia Marcianes; Sofia Negro; Luis García-García; Consuelo Montejo; Emilia Barcia; Ana Fernández-Carballido
Journal:  Int J Nanomedicine       Date:  2017-03-13

9.  Plasma protein corona modulates the vascular wall interaction of drug carriers in a material and donor specific manner.

Authors:  Daniel J Sobczynski; Phapanin Charoenphol; Michael J Heslinga; Peter J Onyskiw; Katawut Namdee; Alex J Thompson; Omolola Eniola-Adefeso
Journal:  PLoS One       Date:  2014-09-17       Impact factor: 3.240

10.  Distribution of β-carotene-encapsulated polysorbate 80-coated poly(D, L-lactide-co-glycolide) nanoparticles in rodent tissues following intravenous administration.

Authors:  Taiki Miyazawa; Kiyotaka Nakagawa; Takahiro Harigae; Ryo Onuma; Fumiko Kimura; Tomoyuki Fujii; Teruo Miyazawa
Journal:  Int J Nanomedicine       Date:  2015-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.